AMGN – Amgen Inc. – Fundamental analysis, financial statements, key ratios, and fair value analysis

Amgen Inc.

Healthcare
Biotechnology
195.44
6.46
3.42%
208.89
166.05
Stock Current Price
Change
Change %
52 Week High
52 Week Low

Financial Ratios

Earnings per Share (EPS)3.21
EPS Estimate Currrent Qtr3.25
Book Value Per Share22.52
Market Cap 125 Billion
PE Ratio 46.7
Dividend Yield3.0874054

Stock Yield

Stock Return 7 Days6.91%
Stock Return 15 Days0.34%
Stock Return 30 Days -6.01%
Stock Return 3 Months-8.16%
Stock Return One Year9.37%
Stock Return 3 Years11.63%

Stock Technical Analysis

Relative Strengh Index (14)41.2
Average True Range (14)6.07
Momentum (14)-7.43
Simple Moving Average (14) -7.43
Time Series Forecast (14)185.21
Time Series Forecast (30) 200.82

Stock News

Financial Statements

index2014201520162017
Revenue20 Billion22 Billion23 Billion23 Billion
Cost of Revenue4 Billion4 Billion4 Billion4 Billion
Gross Profit16 Billion17 Billion19 Billion19 Billion
Gross Margin (%)77.96%80.49%81.90%82.19%
Selling General and Administrative Expense5 Billion5 Billion5 Billion5 Billion
Other operating expenses4 Billion4 Billion3 Billion3 Billion
Earning Before Interest and Taxes EBIT7 Billion9 Billion10 Billion11 Billion
EBIT/Operating Margin (%)33.18%41.88%45.34%47.71%
Interest Expense1 Billion1 Billion1 Billion1 Billion
Other non-operating expenses/income0000
Earnings before Tax6 Billion8 Billion9 Billion10 Billion
Income Tax Expense427 Million1 Billion1 Billion8 Billion
Net Income5 Billion7 Billion8 Billion2 Billion
Net Margin (%)25.71%32.03%33.59%8.66%
Earnings per share from operating income0.19260.144320.1318142.04771
Earnings per Diluted Share6.79.0610.242.69
Dividends per Basic Common Share2.443.1644.6
Payout ratio2.74592.867092.560.584783
Weighted average number of shares outstanding770 Million766 Million754 Million736 Million
index2017 Q42018 Q12018 Q22018 Q3
Revenue6 Billion6 Billion6 Billion6 Billion
Cost of Revenue1 Billion944 Million1 Billion1 Billion
Gross Profit5 Billion5 Billion5 Billion5 Billion
Gross Margin (%)81.75%83.00%83.10%82.44%
Selling General and Administrative Expense1 Billion1 Billion1 Billion1 Billion
Other operating expenses770 Million526 Million688 Million1 Billion
Earning Before Interest and Taxes EBIT3 Billion3 Billion3 Billion2 Billion
EBIT/Operating Margin (%)43.88%53.24%49.41%41.48%
Interest Expense332 Million338 Million347 Million355 Million
Other non-operating expenses/income0000
Earnings before Tax2 Billion3 Billion3 Billion2 Billion
Income Tax Expense6 Billion308 Million351 Million235 Million
Net Income-4 Billion2 Billion2 Billion2 Billion
Net Margin (%)-100.00%41.61%37.89%31.49%
Earnings per share from operating income0.1034820.3937020.3747150.460621
Earnings per Diluted Share-63.253.482.86
Dividends per Basic Common Share1.151.321.321.32
Payout ratio-52.462122.636362.16667
Weighted average number of shares outstanding739 Million711 Million660 Million650 Million
index2014201520162017
Cash and Equivalents4 Billion4 Billion3 Billion4 Billion
Trade and Non Trade Receivables3 Billion3 Billion3 Billion3 Billion
Inventory3 Billion2 Billion3 Billion3 Billion
Other current assets33 Billion37 Billion43 Billion47 Billion
Current Assets35 Billion39 Billion46 Billion49 Billion
Total Non-Current Assets34 Billion33 Billion32 Billion30 Billion
Total Assets69 Billion71 Billion78 Billion80 Billion
Trade and Non Trade Payables995 Million965 Million917 Million1 Billion
Other current liabilities6 Billion8 Billion10 Billion8 Billion
Current Liabilities7 Billion9 Billion11 Billion9 Billion
Liabilities Non Current36 Billion35 Billion37 Billion46 Billion
Accumulated Retained Earnings Deficit-5 Billion-2 Billion-438 Million-5 Billion
Shareholder’s equity other30 Billion30 Billion30 Billion30 Billion
Shareholders Equity26 Billion28 Billion30 Billion25 Billion
Noncontrolling interests14 Billion17 Billion22 Billion18 Billion
Total Assets69 Billion71 Billion78 Billion80 Billion
index2017 Q42018 Q12018 Q22018 Q3
Cash and Equivalents4 Billion10 Billion10 Billion12 Billion
Trade and Non Trade Receivables3 Billion4 Billion4 Billion3 Billion
Inventory3 Billion3 Billion3 Billion3 Billion
Other current assets47 Billion44 Billion42 Billion44 Billion
Current Assets49 Billion41 Billion38 Billion38 Billion
Total Non-Current Assets30 Billion30 Billion30 Billion29 Billion
Total Assets80 Billion71 Billion68 Billion67 Billion
Trade and Non Trade Payables1 Billion1 Billion1 Billion1 Billion
Other current liabilities8 Billion9 Billion10 Billion11 Billion
Current Liabilities9 Billion10 Billion11 Billion12 Billion
Liabilities Non Current46 Billion45 Billion42 Billion41 Billion
Accumulated Retained Earnings Deficit-5 Billion-14 Billion-15 Billion-16 Billion
Shareholder’s equity other30 Billion30 Billion30 Billion30 Billion
Shareholders Equity25 Billion16 Billion15 Billion14 Billion
Noncontrolling interests18 Billion21 Billion22 Billion25 Billion
Total Assets80 Billion71 Billion68 Billion67 Billion
index2014201520162017
Net Cash Flow from Operations9 Billion10 Billion10 Billion11 Billion
Capital Expenditure-715 Million-320 Million-660 Million-653 Million
Net Cash Flow from Investing-6 Billion-6 Billion-9 Billion-4 Billion
Net Cash Flow from Financing-3 Billion-4 Billion-3 Billion-7 Billion
Cash and Equivalents4 Billion4 Billion3 Billion4 Billion
index2017 Q42018 Q12018 Q22018 Q3
Net Cash Flow from Operations3 Billion3 Billion2 Billion3 Billion
Capital Expenditure-142 Million-155 Million-187 Million-171 Million
Net Cash Flow from Investing-78 Million15 Billion3 Billion1 Billion
Net Cash Flow from Financing-2 Billion-12 Billion-5 Billion-3 Billion
Cash and Equivalents4 Billion10 Billion10 Billion12 Billion

Stock Price History

table